Page results
-
This year marks the 20th anniversary of the University College Hospital building. On Monday 29 September, we held a special event open to all our staff and welcomed back some of the people who were involved in building the hospital.
-
A new gene therapy to treat Huntington’s disease has shown positive data from the study of AMT-130 which is being run at UCLH and other sites.
-
We’re proud that UCLH is ranked number one of all acute teaching trusts in new national league tables published today.
-
October is free wills month. We have partnered with Octopus Legacy and are pleased to offer a free will writing service to all our supporters.
-
A new specialist blood transfusion service at Luton and Dunstable University Hospital is transforming care for people living with sickle cell disease (SCD) across the East of England.
-
Doctors at UCLH and University College London (UCL) have developed a digital decision-making aid, MENO.pause, to help clinicians manage menopause symptoms in the best way for individual patients’ health conditions.
-
A new toolkit to support babies, children and young people in healthcare access high quality health play services was launched at UCLH last week with UCLH chief nurse Vanessa Sweeney welcoming visitors from NHS England and the play charity Starlight.
-
The first ever treatment for the rare neurodegenerative disease Friedreich’s ataxia – for which UCLH and UCL led the UK trial – has been approved for use in the UK by the medicines’ regulator.
-
We’re delighted to announce that our Grafton Way Elective Surgical Hub has been successfully accredited as an elective surgical hub delivering high standards in clinical and operational practice.
-
A new research project spearheaded by the CCTU at UCLH is trying to make more places on clinical trials available to young cancer patients aged between 16 and 24 years.
File results
-
FOI/2024/0381 - Proton Beam Therapy Centre material use, architectural technology and performance
-
FOI/2024/0385 - Immunoglobulin vials (by brands) distributed to patients
-
FOI/2024/0386 - Stonewall funding for 2022/23-2023/24
-
FOI/2024/0391 - Hospital admissions due to psychedelics consumption
-
FOI/2024/0404 - Senior HR/ Workforce staff contact details
-
FOI/2024/0409 - Number of A&E attendees with mental health complaints from 2022 to 2024
-
FOI/2024/0415 - Biologic and targeted medications within dermatology medicine
-
FOI/2024/0550 - Syntometrine vs Misoprostol/ treatment uses for post-partum haemorrhage
-
FOI/2024/0537 - SHO doctor shifts covered by physician associates December 2023-May 2024
-
FOI/2024/0554 - Robotic Process Automation (RPA) Programme